Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Linz

Showing results (21-30 of 121) with videos related to

Pageof 13
Sort By:
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|December 1, 1988
Effects of the angiotensin converting enzyme inhibitor, ramipril, in isolated ischaemic rat heart are abolished by a bradykinin antagonistB A Schölkens, W Linz, W König
The American Journal of Cardiology|August 4, 1997
Beneficial effects of bradykinin on myocardial energy metabolism and infarct sizeW Linz, G Wiemer, B A Schölkens
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|December 1, 1993
Bradykinin prevents left ventricular hypertrophy in ratsW Linz, G Wiemer, B A Schölkens
Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Medicas E Biologicas|August 1, 1994
Cardioprotective actions of bradykinin in myocardial ischemia and left ventricular hypertrophyW Linz, G Wiemer, B A Schölkens
Clinical and Experimental Hypertension. Part A, Theory and Practice|January 1, 1989
Converting enzyme inhibition specifically prevents the development and induces regression of cardiac hypertrophy in ratsW Linz, B A Schölkens, D Ganten
Clinical and Experimental Hypertension. Part A, Theory and Practice|January 1, 1987
Heart and vascular wall as targets for tissue converting enzyme inhibitionB A Schölkens, W Linz, Y F Han
Journal of Cardiovascular Pharmacology|January 1, 1991
Experimental cardiovascular benefits of angiotensin-converting enzyme inhibitors: beyond blood pressure reductionB A Schölkens, W Linz, P A Martorana
Journal of Cardiovascular Pharmacology|January 1, 1989
Pharmacological interference with the cardiac renin-angiotensin systemR H Becker, W Linz, B A Schölkens
Journal of Cardiovascular Pharmacology|January 1, 1986
Beneficial effects of the converting enzyme inhibitor, ramipril, in ischemic rat heartsW Linz, B A Schölkens, Y F Han
Zeitschrift Fur Kardiologie|January 1, 1994
[Reduction of infarct size and remodeling after ramipril]P A Martorana, W Linz, B A Schölkens
Pageof 13

Showing results (21-30 of 121) with videos related to

Sort By:
Pageof 13
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|December 1, 1988
Effects of the angiotensin converting enzyme inhibitor, ramipril, in isolated ischaemic rat heart are abolished by a bradykinin antagonistB A Schölkens, W Linz, W König
The American Journal of Cardiology|August 4, 1997
Beneficial effects of bradykinin on myocardial energy metabolism and infarct sizeW Linz, G Wiemer, B A Schölkens
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|December 1, 1993
Bradykinin prevents left ventricular hypertrophy in ratsW Linz, G Wiemer, B A Schölkens
Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Medicas E Biologicas|August 1, 1994
Cardioprotective actions of bradykinin in myocardial ischemia and left ventricular hypertrophyW Linz, G Wiemer, B A Schölkens
Clinical and Experimental Hypertension. Part A, Theory and Practice|January 1, 1989
Converting enzyme inhibition specifically prevents the development and induces regression of cardiac hypertrophy in ratsW Linz, B A Schölkens, D Ganten
Clinical and Experimental Hypertension. Part A, Theory and Practice|January 1, 1987
Heart and vascular wall as targets for tissue converting enzyme inhibitionB A Schölkens, W Linz, Y F Han
Journal of Cardiovascular Pharmacology|January 1, 1991
Experimental cardiovascular benefits of angiotensin-converting enzyme inhibitors: beyond blood pressure reductionB A Schölkens, W Linz, P A Martorana
Journal of Cardiovascular Pharmacology|January 1, 1989
Pharmacological interference with the cardiac renin-angiotensin systemR H Becker, W Linz, B A Schölkens
Journal of Cardiovascular Pharmacology|January 1, 1986
Beneficial effects of the converting enzyme inhibitor, ramipril, in ischemic rat heartsW Linz, B A Schölkens, Y F Han
Zeitschrift Fur Kardiologie|January 1, 1994
[Reduction of infarct size and remodeling after ramipril]P A Martorana, W Linz, B A Schölkens
Pageof 13